Senior insider sale
PROTAGONIST THERAPEUTICS, INC — senior position signals high conviction
$5.92M
59.13K shares
What this filing means
GIRAUDO BRYAN plans to sell 59.13K shares of PROTAGONIST THERAPEUTICS, INC valued at approximately $5.92M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/8/2026ACC: 0001950047-26-004264
Director
Since Jun 2019
59.13K
Shares to sell
$5.92M
Approx. market value
11.13K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Compensation
Not Applicable
1/15/2026
5.13KCompensation
Not Applicable
12/3/2019
6KTotal acquired11.13K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/15/2026 | Compensation Not Applicable | 5.13K | — |
12/3/2019 | Compensation Not Applicable | 6K | — |
| Total | 11.13K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
12K
Market value
$1.20M
5/7/2026
—Completed
Units to sell
36K
Market value
$3.60M
5/7/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
11.13K
Market value
$1.11M
5/8/2026
Total
Units
59.13K
Value
$5.92M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/7/2026 | 12K | $1.20M | — | Completed |
5/7/2026 | 36K | $3.60M | — | Completed |
| Planned — Approximate Date | ||||
5/8/2026 | 11.13K | $1.11M | NASDAQ | Planned |
| Total | 59.13K | $5.92M | ||